Section Arrow
CLDX.NASDAQ
- Celldex Therapeutics
Quotes are at least 15-min delayed:2025/03/28 08:23 EDT
Last
 19.98
+0.41 (+2.10%)
Day High 
20.38 
Prev. Close
19.57 
1-M High
22.33 
Volume 
574.14K 
Bid
18.56
Ask
24
Day Low
19.49 
Open
19.65 
1-M Low
18.61 
Market Cap 
1.30B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 20.08 
20-SMA 20.27 
50-SMA 22.01 
52-W High 47 
52-W Low 18.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.45/-3.88
Enterprise Value
1.30B
Balance Sheet
Book Value Per Share
11.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.02M
Operating Revenue Per Share
0.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.